A comprehensive review on Covid-19 Omicron (B.1.1.529) variant

被引:25
|
作者
Manjunath, R. [1 ]
Gaonkar, Santosh L. [1 ]
Saleh, Ebraheem Abdu Musad [2 ]
Husain, Kakul [2 ]
机构
[1] Manipal Acad Higher Educ, Manipal Inst Technol, Dept Chem, Manipal 576104, Karnataka, India
[2] Prince Sattam Bin Abdulaziz Univ, Coll Arts & Sci, Dept Chem, Wadi Al Dawasir 11991, Saudi Arabia
关键词
Omicron (B; 1; 529); Receptor binding domain (RBD); Spike protein; Monoclonal antibodies(mAb); Titers; Phylogeny; Lineage; Clade; SCIENTISTS;
D O I
10.1016/j.sjbs.2022.103372
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The world has been combating different variants of SARS-COV-19 since its first outbreak in Wuhan city. SARS-COV-19 is caused by the coronavirus. The corona virus mutates and becomes more transmissible than earlier variants as the day passes. Till 24 November 2021, SARS-COV-19 has four variants Alpha, Beta, Gamma, and Delta, respectively. Among them, the delta variant caused severe havoc across the world. South Africa registered a new variant with the World Health Organization (WHO) on 24 November 2021, which is much more transmissible than previous variants. The WHO classified it as a variant of concern (VOC) on 26 November 2021 and called it the Greek letter Omicron (B.1.1.529), the fifteenth letter in the alphabet. Here a serious attempt was made to comprehend the omicron variant's origin, nomenclature, characteristics, mutations, the difference between delta and omicron variant, epi-demiology, transmission, clinical features, impact on immunity, immune evasion, vaccines efficacy, etc.(c) 2022 Published by Elsevier B.V. on behalf of King Saud University. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页数:18
相关论文
共 50 条
  • [41] Characteristics and outcomes of COVID-19 patients during B.1.1.529 (Omicron) dominance compared to B.1.617.2 (Delta) in 89 German hospitals
    Leiner, Johannes
    Pellissier, Vincent
    Hohenstein, Sven
    Koenig, Sebastian
    Schuler, Ekkehard
    Moeller, Robert
    Nachtigall, Irit
    Bonsignore, Marzia
    Hindricks, Gerhard
    Kuhlen, Ralf
    Bollmann, Andreas
    [J]. BMC INFECTIOUS DISEASES, 2022, 22 (01)
  • [42] Characteristics and outcomes of COVID-19 patients during B.1.1.529 (Omicron) dominance compared to B.1.617.2 (Delta) in 89 German hospitals
    Johannes Leiner
    Vincent Pellissier
    Sven Hohenstein
    Sebastian König
    Ekkehard Schuler
    Robert Möller
    Irit Nachtigall
    Marzia Bonsignore
    Gerhard Hindricks
    Ralf Kuhlen
    Andreas Bollmann
    [J]. BMC Infectious Diseases, 22
  • [43] The fourth COVID-19 vaccine dose increased the neutralizing antibody response against the SARS-CoV-2 Omicron (B.1.1.529) variant in a diverse Brazilian population
    Farias, Jessica Pires
    Andreata-Santos, Robert
    Brito, Ruth Dalety da Silva
    Souza, Milena Silva
    Fogaca, Mayanna Moreira Costa
    Pinheiro, Josilene Ramos
    da Cruz, Edgar Ferreira
    Liang, Willian
    Simoes, Rafael da Conceicao
    Luiz, Wilson Barros
    Birbrair, Alexander
    Vidal, Paloma Oliveira
    Maricato, Juliana Terzi
    Braconi, Carla Torres
    Ferreira, Luis Carlos de Souza
    Janini, Luiz Mario Ramos
    Amorim, Jaime Henrique
    [J]. MICROBIOLOGY SPECTRUM, 2023,
  • [44] SARS-CoV-2 Omicron (B.1.1.529) Variant: Corticosteroids Treatment/Respiratory Coinfection
    Elkoshi, Zeev
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [45] Cutting Edge: T Cell Responses to B.1.1.529 (Omicron) SARS-CoV-2 Variant Induced by COVID-19 Infection and/or mRNA Vaccination Are Largely Preserved
    Jergovic, Mladen
    Coplen, Christopher P.
    Uhrlaub, Jennifer L.
    Beitel, Shawn C.
    Burgess, Jefferey L.
    Lutrick, Karen
    Ellingson, Katherine D.
    Watanabe, Makiko
    Nikolich-Zugich, Janko
    [J]. JOURNAL OF IMMUNOLOGY, 2022, 208 (11): : 2461 - 2465
  • [46] Paediatric hospitalisations due to COVID-19 during the first SARS-CoV-2 omicron (B.1.1.529) variant wave in South Africa: a multicentre observational study
    Cloete, Jeane
    Kruger, Annelet
    Masha, Maureen
    du Plessis, Nicolette M.
    Mawela, Dini
    Tshukudu, Mphailele
    Manyane, Tabea
    Komane, Lekwetji
    Venter, Marietjie
    Jassat, Waasila
    Goga, Ameena
    Feucht, Ute
    [J]. LANCET CHILD & ADOLESCENT HEALTH, 2022, 6 (05): : 294 - 302
  • [47] Omicron variant (B.1.1.529) of SARS-CoV-2: Threat assessment and plan of action
    Choudhary, Om Prakash
    Dhawan, Manish
    Priyanka
    [J]. INTERNATIONAL JOURNAL OF SURGERY, 2022, 97
  • [48] The rapid replacement of the SARS-CoV-2 Delta variant by Omicron (B.1.1.529) in England
    Paton, Robert S.
    Overton, Christopher E.
    Ward, Thomas
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2022, 14 (652)
  • [49] Omicron (B.1.1.529) variant of SARS-CoV-2: Concerns, challenges, and recent updates
    Mohapatra, Ranjan K.
    Tiwari, Ruchi
    Sarangi, Ashish K.
    Islam, Md. Rabiul
    Chakraborty, Chiranjib
    Dhama, Kuldeep
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (06) : 2336 - 2342
  • [50] Steep Decline in Binding Capability of SARS-CoV-2 Omicron Variant (B.1.1.529) RBD to the Antibodies in Early COVID-19 Convalescent Sera and Inactivated Vaccine Sera
    Zhou, Wenhao
    He, Ping
    Li, Junhua
    Liu, Huan
    Shi, Mengjuan
    Yu, Junping
    Wei, Hongping
    [J]. VIRUSES-BASEL, 2022, 14 (02):